,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription
L
FT L
FT FT L L
FT FT L L
FT FT L FT L L
FT
Writing
FT L
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
T
FL L
T
F FT L L
T
F T
FL L
FT L
T
F T
F L
MULTIPLE CHOICE FT L
1. Knowledge of pharmacology aids the dental professional in L
FT FT L L
FT FT L FT L FT L FT L
a. obtaining a patient’s health history. FT L FT L FT L FT L
b. administering drugs in the office. L
FT FT L FT L FT L
c. handling emergency situations. FTL L
FT
d. selection of a nonprescription medication. FT L FT L FT L FT L
e. All of the above. FT L FT L L
FT
ANS: F T L E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
FT L FT L FT L FT L L
FT L
FT FT L FT L FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
pharmacology helps in understanding and interpreting patients’ responses to health history questions.
FT L FT L L
FT L
FT FT L L
FT FT L L
FT L
FT L
FT FT L L
FT
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
FT L FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
FT L FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L L
FT FT L FT L
knowledge of pharmacology is of great help, especially because a rapid response is sometimes
FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
required. A clear understanding of the concepts of drug action, drug handling by the body, and drug
FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L FT L L
FT
interactions will allow the dental practitioner to make proper judgments and grasp the concepts
FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L FT L
relevant to new drug therapies on the market.
FT L FT L FT L L
FT FT L FT L FT L FT L
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist
F T L FT L L
FT L
FT L
FT FT L FT L FT L FT L L
FT L
FT L
FT
(Medication Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental
L
FT FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT
Hygienist (Nonprescription Medication) | pp. 2-3 OBJ:
FT L 1 FT L FT L FT L FT L FT L
TOP: NBDHE, 6.0. Pharmacology F T L L
FT L
FT
2. Which of the following statements is true regarding planning appointments?
FT L L
FT L
FT L
FT FT L FT L FT L L
FT L
FT
a. Whether or not patients are taking medication for systemic diseases is of little FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT FT L FT L FT L
consequence in the dental office. L
FT FT L FT L FT L
b. Asthmatic patients should have dental appointments in the morning. FT L FT L FT L FT L FT L FT L FT L FT L
c. Diabetic patients usually have fewer problems with a morning appointment FTL FT L L
FT L
FT FT L L
FT FT L L
FT L
FT
compared with afternoon appointments.
FT L FT L FT L FT L
d. Both B and C are true. L
FT L
FT FT L FT L L
FT
ANS: F T L D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are L
FT L
FT FT L FT L L
FT L
FT L
FT FT L L
FT L
FT L
FT FT L
not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
FT L FT L FT L L
FT L
FT FT L FT L FT L FT L L
FT L
FT L
FT FT L L
FT FT L
problems with a morning appointment. Patients taking medication for systemic diseases may require
FT L L
FT L
FT FT L FT L FT L L
FT L
FT L
FT FT L L
FT L
FT L
FT
special handling in the dental office.
FT L FT L FT L FT L L
FT FT L
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |
F T L FT L L
FT L
FT L
FT FT L FT L FT L
p. 3 OBJ:
L
FT L
FT 1 TOP: FTNBDHE, 6.0. Pharmacology
L F T L F T L L
FT FT L
,3. Nutritional or herbal supplements FT L FT L FT L
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states. L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L L
FT
b. are not drugs. L
FT L
FT
c. can cause adverse effects. L
FT FT L FT L
d. will not interact with other drugs the patient may be taking. L
FT L
FT L
FT L
FT L
FT FT L FT L FT L L
FT L
FT
ANS: F T L C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of FT L L
FT L
FT FT L FT L L
FT L
FT FTL L
FT FT L L
FT FT L L
FT
nutritional or herbal supplements do not carry FDA approval for treating disease states. These
FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L
supplements are drugs and can cause adverse effects and interact with different drugs.
FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FTL
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
F T L FT L FT L FT L FTL L
FT L
FT L
FT L
FT L
FT
p. 3 OBJ:
L
FT 1 TOP:
FT L NBDHE, 6.0. Pharmacology
L
FT F T L F T L FT L FT L
4. Which type of drug name usually begins with a lowercase letter? FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L
a. Brand name L
FT
b. Code name FT L
c. Generic name L
FT
d. Trade name L
FT
ANS: F T L C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug.
FT L L
FT FT L FT L L
FT L
FT FT L L
FT FTL FT L FT L L
FT L
FT L
FT FT L FT L FT L L
FT
Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the
FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L
name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Although
FT L FT L FT L L
FT FT L FT L FT L FT L L
FT FT L L
FT FT L FT L FT L FT L FT L FT L
the brand name is technically the name of the company marketing the product, this term is often used
FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT
interchangeably with the trade name. The code name is the initial term used within a pharmaceutical
FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L
company to refer to a drug while it is undergoing investigation and is often a combination of capital
FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
letters and numbers, the letters representing an abbreviation of the company name.
FT L FT L FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L
DIF: Comprehension REF: Drug Names | F T L L
FT L
FT
p. 4 OBJ:
L
FT 3 TOP:
L
FT FT L F T L F T L NBDHE, 6.0. Pharmacology FT L FT L
5. A drug’s generic name is selected by the
L
FT FT L L
FT L
FT L
FT L
FT FT L
a. pharmaceutical company manufacturing it. FT L L
FT FT L
b. Food and Drug Administration (FDA). FT L FT L L
FT L
FT
c. U.S. Adopted Name Council. L
FT FT L FT L
d. Federal Patent Office. L
FT FT L
ANS: F T L C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L
Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The
FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
pharmaceutical company manufacturing the drug clearly has an influence on the generic name given
FT L FT L FT L L
FT L
FT FT L FT L FT L FT L L
FT L
FT FT L L
FT FT L
its drug, but the final decision is not the company’s.
FT L L
FT FT L FT L FT L FT L L
FT FT L FT L FT L
DIF: Recall REF: Drug Names | p. 4 F T L FT L FT L L
FT FT L OBJ:
F 3 TOP:T NBDHE, 6.0. Pharmacology
L FT L F T L FT L FT L
6. Which of the following is true concerning generic and trade names of drugs?
FT L FTL L
FT FT L FT L FT L L
FT FT L FT L L
FT FT L FT L
a. A drug may only have one generic name and one trade name.
L
FT FT L L
FT FT L FT L FT L FTL FT L FT L FT L FT L
, b. A drug may only have one generic name, but it may have several trade names.
FT L FT L L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
c. A drug may have several generic names, but it may only have one trade name.
FT L FT L L
FT L
FT FT L FT L FT L FT L FT L L
FT L
FT FT L FT L L
FT
d. A drug may have several generic names and several trade names.
FT L FT L FT L FT L FT L L
FT FT L L
FT L
FT FT L
ANS: F T L B
Each drug has only one generic name but may have several trade names. For each drug, there is only
FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
one generic name. It is not capitalized, and it becomes the “official” name of the drug. The
FT L FT L FT L L
FT L
FT FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT
pharmaceutical company discovering the drug gives the drug a trade name. The trade name is
FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term
FT L FT L L
FT L
FT FT L L
FT FT L L
FT FT L FT L L
FT L
FT FT L FT L L
FT L
FT FT L FT L
extensions. Although the brand name is technically the name of the company marketing the product,
FT L L
FT L
FT L
FT FT L FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT L
FT
it is often used interchangeably with the trade name.
FT L FT L FT L FTL FT L FT L FT L L
FT FT L
DIF: Comprehension REF: Drug Names | F T L L
FT L
FT
p. 4 OBJ:
L
FT 3 L
FT TOP: FT L F T L F T L NBDHE, 6.0. Pharmacology FTL FT L
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or
L
FT L
FT FTL FT L L
FT L
FT FT L FT L FT L FT L L
FT FT L L
FT
FT therapeutically equivalent are said to differ in
L FT L FT L L
FT L
FT FT L FT L
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. FT L
ANS: F T L C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
products are said to differ in their bioavailability. The potency of a drug is a function of the amount of
FT L L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT L
FT FT L L
FT
drug required to produce an effect. The efficacy is the maximum intensity of effect or response that
FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the
FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L
experimental animals divided by the effective dose for 50% of the experimental animals. If the value
FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L
of the therapeutic index is small, toxicity is more likely.
FT L FT L FTL FT L L
FT FT L FT L FT L FT L FT L
DIF: Recall REF: F T L Drug Names (Drug Substitution) | L
FT FT L L
FT L
FT
p. 5 OBJ:
L
FT 4 FT L FT L F T L TOP: F T L NBDHE, 6.0. Pharmacology FTL FT L
8. How many years must pass after a drug patent expires before other drug companies can market the
L
FT FT L L
FT FT L FT L L
FT FT L FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
FT L same compound as a generic drug? FT L FT L FT L L
FT FT L
a. 20 years FT L
b. 17 years FT L
c. 7 years FT L
d. 0 years FT L
ANS: F T L D
Once a drug patent expires, competing companies may immediately market the same compound in
FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L L
FT FT L
generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The
FT L FT L FT L FT L L
FT L
FT L
FT FT L FT L FT L FT L FT L FT L FT L L
FT
trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date,
FT L FT L L
FT FT L FT L L
FT FT L L
FT L
FT FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
plus the patent term extensions.
FT L FT L FT L FT L FT L
DIF: Application REF: F T L Drug Names (Drug Substitution) | L
FT FT L L
FT L
FT
p. 5 OBJ:
L
FT 4 FT L FT L F T L TOP: F T L NBDHE, 6.0. Pharmacology FTL FT L
L
FT L
FT FT L L
FT FT L L
FT FT L FT L L
FT
Writing
FT L
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
T
FL L
T
F FT L L
T
F T
FL L
FT L
T
F T
F L
MULTIPLE CHOICE FT L
1. Knowledge of pharmacology aids the dental professional in L
FT FT L L
FT FT L FT L FT L FT L
a. obtaining a patient’s health history. FT L FT L FT L FT L
b. administering drugs in the office. L
FT FT L FT L FT L
c. handling emergency situations. FTL L
FT
d. selection of a nonprescription medication. FT L FT L FT L FT L
e. All of the above. FT L FT L L
FT
ANS: F T L E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
FT L FT L FT L FT L L
FT L
FT FT L FT L FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
pharmacology helps in understanding and interpreting patients’ responses to health history questions.
FT L FT L L
FT L
FT FT L L
FT FT L L
FT L
FT L
FT FT L L
FT
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
FT L FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
FT L FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L L
FT FT L FT L
knowledge of pharmacology is of great help, especially because a rapid response is sometimes
FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
required. A clear understanding of the concepts of drug action, drug handling by the body, and drug
FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L FT L L
FT
interactions will allow the dental practitioner to make proper judgments and grasp the concepts
FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L FT L
relevant to new drug therapies on the market.
FT L FT L FT L L
FT FT L FT L FT L FT L
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist
F T L FT L L
FT L
FT L
FT FT L FT L FT L FT L L
FT L
FT L
FT
(Medication Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental
L
FT FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT
Hygienist (Nonprescription Medication) | pp. 2-3 OBJ:
FT L 1 FT L FT L FT L FT L FT L
TOP: NBDHE, 6.0. Pharmacology F T L L
FT L
FT
2. Which of the following statements is true regarding planning appointments?
FT L L
FT L
FT L
FT FT L FT L FT L L
FT L
FT
a. Whether or not patients are taking medication for systemic diseases is of little FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT FT L FT L FT L
consequence in the dental office. L
FT FT L FT L FT L
b. Asthmatic patients should have dental appointments in the morning. FT L FT L FT L FT L FT L FT L FT L FT L
c. Diabetic patients usually have fewer problems with a morning appointment FTL FT L L
FT L
FT FT L L
FT FT L L
FT L
FT
compared with afternoon appointments.
FT L FT L FT L FT L
d. Both B and C are true. L
FT L
FT FT L FT L L
FT
ANS: F T L D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are L
FT L
FT FT L FT L L
FT L
FT L
FT FT L L
FT L
FT L
FT FT L
not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
FT L FT L FT L L
FT L
FT FT L FT L FT L FT L L
FT L
FT L
FT FT L L
FT FT L
problems with a morning appointment. Patients taking medication for systemic diseases may require
FT L L
FT L
FT FT L FT L FT L L
FT L
FT L
FT FT L L
FT L
FT L
FT
special handling in the dental office.
FT L FT L FT L FT L L
FT FT L
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |
F T L FT L L
FT L
FT L
FT FT L FT L FT L
p. 3 OBJ:
L
FT L
FT 1 TOP: FTNBDHE, 6.0. Pharmacology
L F T L F T L L
FT FT L
,3. Nutritional or herbal supplements FT L FT L FT L
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states. L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L L
FT
b. are not drugs. L
FT L
FT
c. can cause adverse effects. L
FT FT L FT L
d. will not interact with other drugs the patient may be taking. L
FT L
FT L
FT L
FT L
FT FT L FT L FT L L
FT L
FT
ANS: F T L C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of FT L L
FT L
FT FT L FT L L
FT L
FT FTL L
FT FT L L
FT FT L L
FT
nutritional or herbal supplements do not carry FDA approval for treating disease states. These
FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L
supplements are drugs and can cause adverse effects and interact with different drugs.
FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FTL
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
F T L FT L FT L FT L FTL L
FT L
FT L
FT L
FT L
FT
p. 3 OBJ:
L
FT 1 TOP:
FT L NBDHE, 6.0. Pharmacology
L
FT F T L F T L FT L FT L
4. Which type of drug name usually begins with a lowercase letter? FT L FT L L
FT FT L FT L L
FT FT L FT L FT L FT L
a. Brand name L
FT
b. Code name FT L
c. Generic name L
FT
d. Trade name L
FT
ANS: F T L C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug.
FT L L
FT FT L FT L L
FT L
FT FT L L
FT FTL FT L FT L L
FT L
FT L
FT FT L FT L FT L L
FT
Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the
FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L
name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Although
FT L FT L FT L L
FT FT L FT L FT L FT L L
FT FT L L
FT FT L FT L FT L FT L FT L FT L
the brand name is technically the name of the company marketing the product, this term is often used
FT L L
FT FT L FT L FT L L
FT FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT
interchangeably with the trade name. The code name is the initial term used within a pharmaceutical
FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L
company to refer to a drug while it is undergoing investigation and is often a combination of capital
FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
letters and numbers, the letters representing an abbreviation of the company name.
FT L FT L FT L FT L FT L L
FT FT L FT L L
FT FT L FT L FT L
DIF: Comprehension REF: Drug Names | F T L L
FT L
FT
p. 4 OBJ:
L
FT 3 TOP:
L
FT FT L F T L F T L NBDHE, 6.0. Pharmacology FT L FT L
5. A drug’s generic name is selected by the
L
FT FT L L
FT L
FT L
FT L
FT FT L
a. pharmaceutical company manufacturing it. FT L L
FT FT L
b. Food and Drug Administration (FDA). FT L FT L L
FT L
FT
c. U.S. Adopted Name Council. L
FT FT L FT L
d. Federal Patent Office. L
FT FT L
ANS: F T L C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L
Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The
FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
pharmaceutical company manufacturing the drug clearly has an influence on the generic name given
FT L FT L FT L L
FT L
FT FT L FT L FT L FT L L
FT L
FT FT L L
FT FT L
its drug, but the final decision is not the company’s.
FT L L
FT FT L FT L FT L FT L L
FT FT L FT L FT L
DIF: Recall REF: Drug Names | p. 4 F T L FT L FT L L
FT FT L OBJ:
F 3 TOP:T NBDHE, 6.0. Pharmacology
L FT L F T L FT L FT L
6. Which of the following is true concerning generic and trade names of drugs?
FT L FTL L
FT FT L FT L FT L L
FT FT L FT L L
FT FT L FT L
a. A drug may only have one generic name and one trade name.
L
FT FT L L
FT FT L FT L FT L FTL FT L FT L FT L FT L
, b. A drug may only have one generic name, but it may have several trade names.
FT L FT L L
FT FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
c. A drug may have several generic names, but it may only have one trade name.
FT L FT L L
FT L
FT FT L FT L FT L FT L FT L L
FT L
FT FT L FT L L
FT
d. A drug may have several generic names and several trade names.
FT L FT L FT L FT L FT L L
FT FT L L
FT L
FT FT L
ANS: F T L B
Each drug has only one generic name but may have several trade names. For each drug, there is only
FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
one generic name. It is not capitalized, and it becomes the “official” name of the drug. The
FT L FT L FT L L
FT L
FT FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT
pharmaceutical company discovering the drug gives the drug a trade name. The trade name is
FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term
FT L FT L L
FT L
FT FT L L
FT FT L L
FT FT L FT L L
FT L
FT FT L FT L L
FT L
FT FT L FT L
extensions. Although the brand name is technically the name of the company marketing the product,
FT L L
FT L
FT L
FT FT L FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT L
FT
it is often used interchangeably with the trade name.
FT L FT L FT L FTL FT L FT L FT L L
FT FT L
DIF: Comprehension REF: Drug Names | F T L L
FT L
FT
p. 4 OBJ:
L
FT 3 L
FT TOP: FT L F T L F T L NBDHE, 6.0. Pharmacology FTL FT L
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or
L
FT L
FT FTL FT L L
FT L
FT FT L FT L FT L FT L L
FT FT L L
FT
FT therapeutically equivalent are said to differ in
L FT L FT L L
FT L
FT FT L FT L
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. FT L
ANS: F T L C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L
products are said to differ in their bioavailability. The potency of a drug is a function of the amount of
FT L L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT L
FT FT L L
FT
drug required to produce an effect. The efficacy is the maximum intensity of effect or response that
FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L
can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the
FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L FT L FT L FT L FT L FT L
experimental animals divided by the effective dose for 50% of the experimental animals. If the value
FT L FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L
of the therapeutic index is small, toxicity is more likely.
FT L FT L FTL FT L L
FT FT L FT L FT L FT L FT L
DIF: Recall REF: F T L Drug Names (Drug Substitution) | L
FT FT L L
FT L
FT
p. 5 OBJ:
L
FT 4 FT L FT L F T L TOP: F T L NBDHE, 6.0. Pharmacology FTL FT L
8. How many years must pass after a drug patent expires before other drug companies can market the
L
FT FT L L
FT FT L FT L L
FT FT L FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
FT L same compound as a generic drug? FT L FT L FT L L
FT FT L
a. 20 years FT L
b. 17 years FT L
c. 7 years FT L
d. 0 years FT L
ANS: F T L D
Once a drug patent expires, competing companies may immediately market the same compound in
FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L L
FT FT L
generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The
FT L FT L FT L FT L L
FT L
FT L
FT FT L FT L FT L FT L FT L FT L FT L L
FT
trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date,
FT L FT L L
FT FT L FT L L
FT FT L L
FT L
FT FT L L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT
plus the patent term extensions.
FT L FT L FT L FT L FT L
DIF: Application REF: F T L Drug Names (Drug Substitution) | L
FT FT L L
FT L
FT
p. 5 OBJ:
L
FT 4 FT L FT L F T L TOP: F T L NBDHE, 6.0. Pharmacology FTL FT L
